about
Idiopathic pulmonary fibrosis.Methodological considerations relevant to epidemiology studies of silica and lung cancerCrystalline silica exposure, radiological silicosis, and lung cancer mortality in diatomaceous earth industry workersFibrogenic potential of intratracheally instilled quartz, ferric oxide, fibrous glass, and hydrated alumina in hamstersPulmonary fibrosis: patterns and perpetratorsPerspectives on pulmonary inflammation and lung cancer risk in cigarette smokersExposure to crystalline silica and risk of lung cancer: the epidemiological evidenceLung cancer and interstitial lung diseases: a systematic reviewHigh-resolution CT of complications of idiopathic fibrotic lung diseaseIn search of a cause of cryptogenic fibrosing alveolitis (CFA): one initiating factor or many?Clinical usefulness of high resolution computed tomography in cryptogenic fibrosing alveolitis.Synchronous double primary lung cancers of squamous and neuroendocrine type associated with cryptogenic fibrosing alveolitis.Asbestos related malignancy and the Cairns hypothesisAsbestosis as a precursor of asbestos related lung cancer: results of a prospective mortality studyAsbestos exposure, asbestosis, and asbestos-attributable lung cancer.Idiopathic pulmonary fibrosis with bronchogenic carcinoma.Pulmonary responses to inhaled poorly soluble particulate in the human.Increased risk for cancer following sarcoidosis.Cancer complicating systemic lupus erythematosus--a dichotomy emerging from a nested case-control study.Malignancy in systemic lupus erythematosus: what have we learned?Recent advances in the aetiology of cryptogenic fibrosing alveolitis.Lung cancer risk in workers exposed to poly(vinyl chloride) dust: a nested case-referent study.A survey of nocturnal hypoxaemia and health related quality of life in patients with cryptogenic fibrosing alveolitisSerum sialyl Lewis X-i antigen in lung adenocarcinoma and idiopathic pulmonary fibrosisDoes cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer?Impact of Preexisting Interstitial Lung Disease on Acute, Extensive Radiation Pneumonitis: Retrospective Analysis of Patients with Lung Cancer.The epidemiology of interstitial lung disease and its association with lung cancer.Clinical features of interstitial lung diseases.Prognosis of cryptogenic fibrosing alveolitis.British Thoracic Society Study on cryptogenic fibrosing alveolitis: Response to treatment and survival.Treatment of small cell lung carcinoma in association with cryptogenic fibrosing alveolitisHigh-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic pulmonary fibrosis.Year in review 2010: interstitial lung diseases, acute lung injury, sleep, physiology, imaging, bronchoscopic intervention and lung cancer.Idiopathic fibrosing alveolitis: a review with emphasis on ultrastructural and immunohistochemical features.Interstitial Lung Disease and Lung Cancer Development: A 5-Year Nationwide Population-Based Study.MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.Treatment of idiopathic pulmonary fibrosis: a position paper from a Nordic expert group.Chemotherapy for extensive-stage small-cell lung cancer with idiopathic pulmonary fibrosis.Incidence of interstitial lung disease in patients with mesothelioma in the west part of Japan.Pirfenidone may revert the epithelial-to-mesenchymal transition in human lung adenocarcinoma.
P2860
Q21202895-4E08F4C6-C7BA-4494-BA10-ED050A135FC6Q23913466-9157298E-AC00-48DE-8B09-7C46A1C00905Q23913468-5ABDFD62-5E93-4DAD-97B1-1677549E7243Q23920416-5D5F1A76-75D5-4EA3-A110-F1E44F65A933Q27694249-7C860401-222B-4917-AC58-81623A44AFABQ28199730-E471A808-606A-4A59-923C-4BD01F80487FQ28385081-2F07BCE8-FF2D-4D86-AC4F-51B1EF212E0FQ28387238-5433E5A9-FC7F-4EBE-9095-0BA165213A08Q30462254-4AE06332-A7BE-433C-BA59-AAA32AB3BE20Q33588114-2955299B-6E5E-4A0C-93D6-F340971CED01Q33589360-18388C6B-A88B-42A9-9777-57DF000F71ECQ33604544-00014799-0515-48C7-9957-9AC984601B3CQ33634211-40DDC857-2F9B-4E14-8144-4A8B38A2AF2EQ33634330-44D99E0C-44B2-431B-AB58-3820D42CEE64Q33776110-6AD46F38-A727-4463-8774-36AE2F45FC79Q33813666-726C957B-E8B0-42CD-8A2D-97FB44596E76Q33861906-8DA2F1E5-DAB1-4A5F-A30F-2EFC4EC6A4A0Q33879770-AF01B36C-6D2D-48C6-AE77-F2A27A2D3DE9Q33937936-4838EAE1-4D6F-48FA-A620-0AEBFBB039AEQ34087859-5CEB116C-4D4A-497E-ACD7-B5F6CFA26FD9Q34105545-43029559-015B-43E0-A0CF-454C408BABBEQ35498678-76978800-CD06-4CC0-8F75-4CF2B1B9768FQ35534550-32A7D5D6-2FBC-40CD-BDED-38805ABA2AEBQ35535035-47E34B29-ADBB-46E8-B3A0-62558EA87937Q35558538-6DDC57C6-64EA-490B-859B-07331B7E5D73Q35804538-2E1C8F31-6808-4ECA-B0C4-9D6EE2BA0670Q35875981-3B807778-90B7-434A-A1FC-11BC1EBFF699Q35938778-58606C2B-3763-4A3A-8148-222C3BC94003Q36128128-FA84C23F-51AA-4791-8F56-5EC89F1CB615Q36203281-6B50D312-AA59-4060-80B5-6A5E1F46CF46Q36717136-7377DD2D-E4D4-481A-8DAE-DBEFC8F61371Q37580715-24680013-7F32-4743-986C-E5D7F6CBD92BQ37829768-218669ED-28B2-4831-8F02-B59EB87CC5ADQ38159441-934CE93C-0C56-4594-B698-E8A9D90A2118Q38791705-A34373B0-55A7-4D7F-828C-16E0FBF1B423Q38917573-12E50221-1AB5-4919-8F9A-B23A16FE3BCFQ39013034-5CB58D74-9138-497A-BF2A-284B8C77D7B0Q39434133-1447573B-97BE-4384-82B1-38F5F10E75D2Q39769492-696043B8-2C35-4907-9E85-2F5C5CEA6B6DQ40979380-351EAF85-6F52-449B-8031-41FE59B9FDCA
P2860
description
1980 nî lūn-bûn
@nan
1980年の論文
@ja
1980年学术文章
@wuu
1980年学术文章
@zh-cn
1980年学术文章
@zh-hans
1980年学术文章
@zh-my
1980年学术文章
@zh-sg
1980年學術文章
@yue
1980年學術文章
@zh
1980年學術文章
@zh-hant
name
Cryptogenic fibrosing alveolitis and lung cancer.
@ast
Cryptogenic fibrosing alveolitis and lung cancer.
@en
type
label
Cryptogenic fibrosing alveolitis and lung cancer.
@ast
Cryptogenic fibrosing alveolitis and lung cancer.
@en
prefLabel
Cryptogenic fibrosing alveolitis and lung cancer.
@ast
Cryptogenic fibrosing alveolitis and lung cancer.
@en
P2093
P2860
P356
P1433
P1476
Cryptogenic fibrosing alveolitis and lung cancer.
@en
P2093
Lebowitz M
Turner-Warwick M
P2860
P304
P356
10.1136/THX.35.7.496
P407
P577
1980-07-01T00:00:00Z